Sebastian Melchior

Summary

Affiliation: Klinikum Bremen-Mitte
Country: Germany

Publications

  1. ncbi Outcome of radical prostatectomy for incidental carcinoma of the prostate
    Sebastian Melchior
    Department of Urology, Johannes Gutenberg University Medical School, Mainz, Germany
    BJU Int 103:1478-81. 2009
  2. ncbi Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis
    Sebastian Melchior
    Department of Urology, Johannes Gutenberg University Medical School, Mainz, Germany
    J Urol 182:978-82. 2009
  3. ncbi Urological de novo malignancy after kidney transplantation: a case for the urologist
    Sebastian Melchior
    Department of Urology Transplantation Centre, Klinikum Bremen Mitte, Bremen, Germany
    J Urol 185:428-32. 2011
  4. ncbi Intussuscepted ileal flap valve for revisional surgery
    Joachim W ThUroff
    Department of Urology, Johannes Gutenberg University, Medical School, Mainz, Germany
    BJU Int 96:1425-37. 2005
  5. ncbi Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer
    Christian Thomas
    Department of Urology, Johannes Gutenberg University, Mainz, Germany
    J Urol 180:1938-41; discussion 1941. 2008
  6. ncbi Simplified orthotopic ileocaecal pouch (Mainz pouch) for bladder substitution
    Joachim W ThUroff
    Department of Urology, Johannes Gutenberg University, Medical School, Mainz, Germany
    BJU Int 96:443-65. 2005
  7. ncbi Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells
    Sandra Kausche
    Department of Medicine III, Hematology and Oncology, University of Mainz, Mainz, Germany
    Cancer Res 66:11447-54. 2006

Collaborators

Detail Information

Publications7

  1. ncbi Outcome of radical prostatectomy for incidental carcinoma of the prostate
    Sebastian Melchior
    Department of Urology, Johannes Gutenberg University Medical School, Mainz, Germany
    BJU Int 103:1478-81. 2009
    ..The decision 'treatment or no treatment' should be determined by the patients' age and life-expectancy, tumour aggressiveness in the TURP specimen and the prostate-specific antigen level after TURP...
  2. ncbi Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis
    Sebastian Melchior
    Department of Urology, Johannes Gutenberg University Medical School, Mainz, Germany
    J Urol 182:978-82. 2009
    ....
  3. ncbi Urological de novo malignancy after kidney transplantation: a case for the urologist
    Sebastian Melchior
    Department of Urology Transplantation Centre, Klinikum Bremen Mitte, Bremen, Germany
    J Urol 185:428-32. 2011
    ..Thus, urologists have an increasing likelihood of treating these cases. We report our experience with the management of urological de novo malignancies after renal transplantation...
  4. ncbi Intussuscepted ileal flap valve for revisional surgery
    Joachim W ThUroff
    Department of Urology, Johannes Gutenberg University, Medical School, Mainz, Germany
    BJU Int 96:1425-37. 2005
  5. ncbi Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer
    Christian Thomas
    Department of Urology, Johannes Gutenberg University, Mainz, Germany
    J Urol 180:1938-41; discussion 1941. 2008
    ..We determined indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer...
  6. ncbi Simplified orthotopic ileocaecal pouch (Mainz pouch) for bladder substitution
    Joachim W ThUroff
    Department of Urology, Johannes Gutenberg University, Medical School, Mainz, Germany
    BJU Int 96:443-65. 2005
  7. ncbi Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells
    Sandra Kausche
    Department of Medicine III, Hematology and Oncology, University of Mainz, Mainz, Germany
    Cancer Res 66:11447-54. 2006
    ..These data encourage the generation of antitumor T-cell products from HLA-identical siblings and their potential use in adoptive immunotherapy of metastatic RCC patients...